about
Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patientsThe Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ TransplantationInfluenza vaccination in immunocompromised patients: efficacy and safety.Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.Polymicrobial vertebral osteomyelitis after oesophageal biopsy: a case reportVentricular assist devices as bridge to heart transplantation: impact on post-transplant infections.Treatment of dyslipidaemia in HIV-infected persons.Late-onset cytomegalovirus disease in patients with solid organ transplant.Bloodstream infections after solid-organ transplantationCandida arteritis in patients who have not received organ transplants: case report and review of the literature.QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovirHuman Cytomegalovirus Infection Enhances NK Cell Activity In Vitro.Microbial Communities of Conducting and Respiratory Zones of Lung-Transplanted Patients.Rapid detection of Staphylococcus aureus strains with reduced susceptibility to vancomycin by isothermal microcalorimetry.Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards.Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology.Infection and chronic allograft dysfunction.Presence of Chlamydiales DNA in samples negative by broad-range bacterial 16S rRNA PCRs: new insights into chlamydial pathogenic role.Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.Influenza vaccination in solid-organ transplant recipients.Relevance of cohort studies for the study of transplant infectious diseases.The swiss transplant cohort study: lessons from the first 6 years.Cytomegalovirus infection in solid organ transplant recipients.Influenza and other respiratory virus infections in solid organ transplant recipients.Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ Transplantation.Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey.Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.[Management of infection after organ transplantation by the primary care physician].Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B Haplotypes.CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.
P50
Q26748718-6A51D0DE-DB93-4B67-A658-301A88EC57C1Q28085440-BF983E26-AE1D-48FF-ADEF-1C61F2728C17Q30358640-BB774CC5-9454-4565-B49F-73F81A5031B2Q30399281-9DEEED5D-7C08-4430-A111-ADE0F54F6F13Q33522300-48828F03-C6A9-45C2-9580-1FBE3D081991Q35895301-FB29459B-8486-40FE-9469-90A9E5918F81Q35977295-7B13AB2A-1070-420F-A5BD-F341DBC3F54EQ36071675-8C142433-A643-4834-A6D9-333D55F8D26DQ36222023-C4D32F22-9B8F-4B2D-9480-1439A522769CQ36869733-E789E0EF-F785-4207-A11E-2651045A2E74Q36913353-BA00B344-B50E-4E2C-AAE6-ADE61BD6CB1BQ37141198-CF4BE87A-AD4F-4E45-8200-0ABD6117A7A6Q37206147-6730792E-0762-4D3F-A9C5-CA597ABF8283Q37247594-F41B7204-FE87-49D1-8940-5C703FD45162Q37381119-38917965-4598-4472-911C-B1A1DBDCC378Q37396846-4F751FC6-90AC-4753-98B4-FB2B319AEC3DQ37546679-F90F9CDD-72B7-4F47-91DA-9E11A4011719Q37588252-12FB830B-9661-4A3A-9AB7-BE49CAA67842Q37589273-7B0570D7-DD00-4B51-A4DF-B2260C2DA757Q37603768-02F9389A-7A4B-46F1-94BB-014F613FB6B4Q37813410-5F50F5BB-E745-4FDF-8EE9-3CC1900A4163Q37836970-5AD24D72-0838-471A-BE2D-6985BAF84FF4Q37949634-86719DAB-ECBC-44B1-81D2-14DC43362448Q37981880-518F9176-03BD-4193-A79D-F40E812B6C26Q38050048-975E463A-0351-4918-A910-0D82E6D0B30BQ38056634-F15EFD09-690C-40DF-9609-DF99C9A37477Q38444815-C253EB0D-2F87-42F6-BAFE-7B9A377AAFACQ38602983-A2CE0C15-46D8-4A55-984C-53B3F318D5A3Q38602985-364D8852-4994-42BA-98FC-FE76D373709DQ38724913-72720B3D-77E6-4708-B08E-D0336B0399E7Q39427348-1AAA864B-CB6B-4FA8-8C35-77F94BA5B710Q39961908-85A521FC-0474-479A-A16F-2BF7E6BDBF22Q40281578-C60569D4-A8F6-4DA4-BC5A-D64B2803B997Q40387904-9A9E2DE7-5A30-4854-A50B-D067792B5A83Q40389617-29DCEEF1-0382-4001-B7B6-C686AD208A47Q40586586-5F4BD4E7-4CE1-4833-A70C-5C7E7442A774Q40661839-3717C49C-89D5-4E05-A77E-748CFBB454FEQ40862720-B8B7C3F3-3F25-4026-A3F2-206C44C736C2Q40880029-7229E743-E2F6-442B-9995-512E4F25CB65Q41047626-AAC1BDE0-BE93-4A0B-8BBB-8F0975FF1C9B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Oriol Manuel
@ast
Oriol Manuel
@en
Oriol Manuel
@es
Oriol Manuel
@nl
Oriol Manuel
@sl
type
label
Oriol Manuel
@ast
Oriol Manuel
@en
Oriol Manuel
@es
Oriol Manuel
@nl
Oriol Manuel
@sl
prefLabel
Oriol Manuel
@ast
Oriol Manuel
@en
Oriol Manuel
@es
Oriol Manuel
@nl
Oriol Manuel
@sl
P108
P106
P21
P31
P496
0000-0001-7607-0943